Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Shrinking team NBB
FTE fell two years in a row, from 94.6 to 84.5.
Financials
Financial year 2025
ZIMMER BIOMET from Machelen (Brab.), company number BE0474708991, closed financial year 2025 with a result of € 3.3 million after tax. For that financial year ZIMMER BIOMET recorded revenue of € 79.9 million and equity of € 37 million. Compared with financial year 2024, the result moved from € 3.2 million to € 3.3 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 9, 2026.
€ 37 million
▲ 10% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 3.3 million
▲ 6% vs 2024
Profit after tax over the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 36.2 million.
People and assets in 2025
84.5
▼ 3.8 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 13.6 million
▼ 2% vs 2024
€ 161,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 1,651
▼ 24% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 16.4 million
▲ 238% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 93 days on average.
€ 4.2 million
▲ 16% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 75,789,370 | € 81,525,609 | € 78,582,002 | € 79,928,408 | ▲ 2% |
| Profit after taxes | € 2,431,958 | € 4,425,648 | € 3,166,987 | € 3,345,485 | ▲ 6% |
| Equity | € 26,047,962 | € 30,473,610 | € 33,640,597 | € 36,986,082 | ▲ 10% |
| Total debts | € 8,300,302 | € 11,863,834 | € 10,451,885 | € 23,018,621 | ▲ 120% |
| Retained profit | € 25,263,841 | € 29,689,489 | € 32,856,476 | € 36,201,961 | ▲ 10% |
| Balance sheet total | € 34,348,264 | € 42,337,444 | € 44,092,482 | € 60,004,703 | ▲ 36% |
| Employees (FTE) | 99.4 | 94.6 | 88.3 | 84.5 | ▼ 3.8 |
Key figures of ZIMMER BIOMET, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to ZIMMER BIOMET?
What happened at ZIMMER BIOMET in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 3.3 million (▲ 6% vs 2024). Source: NBB ↗
- Ann Berghs became a director. NBB
- Jenny Stokke became a director. NBB
- Steven Henri J De Pauw stepped down as director. NBB
- Ann Meulemans became a director. NBB
- Steven Henri J De Pauw became a director. NBB
- Koen Clerinx became a director. NBB
- New establishment in Machelen (Brab.). KBO
In short
From € 2.4 million profit in 2022 to € 3.3 million profit in 2025.
Paid € 5.8 million in corporate taxes since 2022.
Best year ever: 2023, with € 4.4 million profit.
Pays suppliers within 93 days on average.
A new publication or filing at ZIMMER BIOMET? We notify you, reason included.
Follow ZIMMER BIOMETDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind ZIMMER BIOMET are Ann Meulemans, Koen Clerinx, Jenny Stokke and Ann Berghs. The shares are held by Zimmer GmbH (100%) and Zimmer Biomet Nederland B.V. (0%).
Directors
According to the 2025 annual accounts
Ann Meulemans
Director
since 2024
Koen Clerinx
Director
since 2022
Jenny Stokke
Managing director
since 2025
Ann Berghs
Managing director
since 2026
Steven Henri J De Pauw
Managing director
since 2022 · until 2025
Shareholders
Zimmer GmbH
100%
Zimmer Biomet Nederland B.V.
0%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Culliganlaan 2A
1831 Machelen (Brab.)
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0474.708.991
- VAT number
- BE 0474.708.991
- Registered office
- Culliganlaan 2A, 1831 Machelen (Brab.)
- Names & denominations
- ZIMMER BIOMET
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 30 April 2001
- Peppol
- Active · Active since 28 Nov 2025
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten